|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 200-204, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JH Levy, IM Schwieger, JR Zaidan, BA Faraj and WS Weintraub
Patients with neutral protamine Hagedorn and protamine-zinc insulin-
dependent diabetes, a history of fish allergy, or prior vasectomy have been
reported to be at an increased risk for protamine reactions after
cardiopulmonary bypass because of prior sensitization. We prospectively
evaluated cardiac surgical patients with prior vasectomies and fish
allergies and retrospectively evaluated a cohort of 3245 consecutive
cardiac surgical patients requiring cardiopulmonary bypass over a 2- year
period for protamine-containing insulin use and clinical evidence of
adverse reactions after protamine administration for heparin reversal after
cardiopulmonary bypass. Clinical reactions to protamine did not occur in
six patients with fish allergies or 16 patients with prior vasectomies.
There was one reaction (0.6%) in 160 patients with neutral protamine
Hagedorn insulin-dependent diabetes. The incidence of clinical reactions in
the other patients was 2/3085 (0.06%). The incidence of clinical reactions
in the patients with neutral protamine Hagedorn insulin-dependent diabetes
is not significantly different from that in other patients. We conclude
that prior neutral protamine Hagedorn insulin use, a history of fish
allergy, or prior vasectomy does not represent a contraindication to
protamine administration after cardiopulmonary bypass.
ARTICLES
Evaluation of patients at risk for protamine reactions
Emory University School of Medicine, Division of Cardiothoracic Anesthesiology, Atlanta, Ga.
This article has been cited by other articles:
![]() |
M. Sobel and R. Verhaeghe Antithrombotic Therapy for Peripheral Artery Occlusive Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 815S - 843S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Levy and N. F. Adkinson Jr Anaphylaxis During Cardiac Surgery: Implications for Clinicians Anesth. Analg., February 1, 2008; 106(2): 392 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Levy, K. A. Tanaka, and J. M. Bailey Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110. [Full Text] |
||||
![]() |
G. P. Clagett, M. Sobel, M. R. Jackson, G. Y. H. Lip, M. Tangelder, and R. Verhaeghe Antithrombotic Therapy in Peripheral Arterial Occlusive Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 609S - 626S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Levy Anaphylactic Reactions to Neuromuscular Blocking Drugs: Are We Making the Correct Diagnosis? Anesth. Analg., April 1, 2004; 98(4): 881 - 882. [Full Text] [PDF] |
||||
![]() |
D. L. Hepner and M. C. Castells Anaphylaxis During the Perioperative Period Anesth. Analg., November 1, 2003; 97(5): 1381 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Seifert, D. R. Jobes, T. Ten Have, S. E. Kimmel, L. M. Montenegro, J. M. Steven, S. C. Nicolson, and B. L. Strom Adverse Events After Protamine Administration Following Cardiopulmonary Bypass in Infants and Children Anesth. Analg., August 1, 2003; 97(2): 383 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bailey, K. A. Tanaka, and J. H. Levy Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118. [Full Text] |
||||
![]() |
I. Swoboda, A. Bugajska-Schretter, P. Verdino, W. Keller, W. R. Sperr, P. Valent, R. Valenta, and S. Spitzauer Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy J. Immunol., May 1, 2002; 168(9): 4576 - 4584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jackson and G. P. Clagett Antithrombotic Therapy in Peripheral Arterial Occlusive Disease Chest, January 1, 2001; 119(1_suppl): 283S - 299S. [Full Text] [PDF] |
||||
![]() |
D Jegger, H T Tevaearai, J Horisberger, X M Mueller, I Seigneuil, N Pierrel, Y Boone, and L K von Segesser Assembly of the Heparin Removal Device for patients with suspected adverse reaction to protamine sulphate Perfusion, September 1, 2000; 15(5): 453 - 456. [Abstract] [PDF] |
||||
![]() |
A Bugajska-Schretter, M Grote, L Vangelista, P Valent, W R Sperr, H Rumpold, A Pastore, R Reichelt, R Valenta, and S Spitzauer Purification, biochemical, and immunological characterisation of a major food allergen: different immunoglobulin E recognition of the apo- and calcium-bound forms of carp parvalbumin Gut, May 1, 2000; 46(5): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Kimmel, M. A. Sekeres, J. A. Berlin, N. Ellison, V. J. DiSesa, and B. L. Strom Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1916 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Williams, M. N. D'Ambra, T. E. Maione, K. E. Lynch, and D. F. Keene Recombinant platelet factor 4 reversal of heparin in human cardiopulmonary bypass blood J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 975 - 983. [Abstract] [Full Text] |
||||
![]() |
J. H Levy Review article : Anaphylactic reactions during cardiac surgery Perfusion, January 1, 1991; 6(1): 3 - 13. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |